RYLD seeks to generate income through covered call writing, which historically produces higher yields in periods of volatility.1
RYLD has made monthly distributions 5 years running.
RYLD writes call options on the Russell 2000 Index, saving investors the time and potential expense of doing so individually.
1Covered call writing can limit the upside potential of the underlying security
Key Information |
Trading Details |
Distributions |
Taxes |
NAV | Daily Change | |||
Market Price | Daily Change |
Fund NAV | Market Price | Index | |
---|---|---|---|
Options Details |
Net Assets (%) | Ticker | Name | SEDOL | Shares Held | Market Value |
---|---|---|---|---|---|
Exposure |
ETF Characteristics |
ETF Risk Stats |
Option Positions | Notional Exposure | Strike | Upside Before Cap | Expiration Date | Calendar Days to Expiry |
---|---|---|---|---|---|
Short Russell 2000 Call Option | -$1,384,605,603 | 2115 | 0.00% | Jul 18 2025 | 9 |
Return on Equity | 8.30% | |
Weighted Avg. Market Cap | 3,258 M | |
2024 | 2025 | |
Price-to-earnings | 28.36 | 23.86 |
Price-to-book value | 2.03 | 1.91 |
NAV | $15.04 | Daily Change | $0.01 | 0.07% |
Market Price | $15.03 | Daily Change | $0.03 | 0.20% |
VERSUS | BETA |
---|---|
S&P 500 | 0.54 |
NASDAQ-100 | 0.35 |
MSCI EAFE | 0.42 |
MSCI Emg. Mkts | 0.23 |
Standard Deviation | 11.00% |
* The financial statements include the Fund’s disclosures required by Items 7 through 11 of Form N-CSR, which includes the financial statements, financial highlights, and other important information when applicable.
** The financial statements include the Fund’s disclosures required by Items 7 through 11 of Form N-CSR, which includes the financial statements, financial highlights, and other important information when applicable.
As of recent month & quarter-end (Jun 30 2025) | Fund NAV | Market Price | Index |
---|---|---|---|
1 Year | 4.94% | 4.94% | 5.52% |
3 Years | 1.47% | 1.39% | 1.98% |
5 Years | 6.97% | 7.00% | 7.61% |
Since Inception | 3.44% | 3.41% | 4.22% |
Net Assets (%) | Ticker | Name | SEDOL | Market Price ($) | Shares Held | Market Value ($) |
---|---|---|---|---|---|---|
107.11 | RSSL | GLOBAL X RUSSELL 2000 ETF | BR3T756 | 88.30 | 15,770,692 | 1,392,571,028.43 |
0.34 | OTHER PAYABLE & RECEIVABLES | 1.00 | 4,455,717 | 4,455,716.80 | ||
0.00 | CINCOR PHARMA INC - CVR | BMGS153 | 3.06 | 15,984 | 48,911.04 | |
0.00 | INHIBRX INC - CVR | BK1MBC3 | 0.65 | 15,798 | 10,268.70 | |
0.00 | NOVARTIS AG - CVR | 0.39 | 26,043 | 10,156.77 | ||
0.00 | CANADIAN DOLLAR | 0.73 | 7,088 | 5,177.46 | ||
0.00 | PULSE BIOSCIENCES INC WT | 3.06 | 1,148 | 3,512.88 | ||
0.00 | 2324462D | CARTESIAN THERA -CVR | BM9HFX3 | 0.13 | 1 | 0.13 |
0.00 | 2200963D | OMNIAB INC - 12.5 EARNOUT | BP0VHM8 | 0.00 | 2,421 | 0.01 |
0.00 | 2200964D | OMNIAB INC - 15.00 EARNOU | BP0VHL7 | 0.00 | 2,421 | 0.01 |
Holdings are subject to change. "Cash" denotes U.S. dollars.